AI assistant
Sending…
WEST PHARMACEUTICAL SERVICES INC — Director's Dealing 2015
Feb 25, 2015
30339_dirs_2015-02-25_b887063f-e1f6-4e24-a810-34a2a81c91f4.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: WEST PHARMACEUTICAL SERVICES INC (WST)
CIK: 0000105770
Period of Report: 2015-02-23
Reporting Person: Flynn Karen (President, Pharma Pckg Systems)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2015-02-23 | Stock Option (Right to Buy) | $54.1400 | A | 29440.0000 | Acquired | 2025-02-23 | Common Stock (29440.0000) | Direct |
More from WEST PHARMACEUTICAL SERVICES INC
Regulatory Filings
2026
May 20
Regulatory Filings
2026
May 13
Regulatory Filings
2026
May 11
Regulatory Filings
2026
May 5
Major Shareholding Notification
2026
Apr 30
Major Shareholding Notification
2026
Apr 29
Interim / Quarterly Report
2026
Apr 23
Regulatory Filings
2026
Apr 23
Major Shareholding Notification
2026
Mar 27
Proxy Solicitation & Information Statement
2026
Mar 12